Hydroxyprogesterone caproate is an active pharmaceutical ingredient used in the manufacturing of medications. It was developed for use in pharmaceutical preparations aimed at reducing the risk of preterm birth in specific high-risk pregnancies, though its FDA approval was withdrawn in 2023.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing HYDROXYPROGESTERONE CAPROATE?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Hydroxyprogesterone acetate
pharmaceutical raw material
Prednisolone sodium metazoate
pharmaceutical raw material
Phenytoin sodium
pharmaceutical raw material
AST-487
pharmaceutical raw material
Terazosin hydrochloride
pharmaceutical raw material
The international HS code for HYDROXYPROGESTERONE CAPROATE (CAS 630-56-8) is 2937.23.
2937.23
2937 23 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
[(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate
DOMWKUIIPQCAJU-LJHIYBGHSA-N
CCCCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C(=O)C
Sourcing HYDROXYPROGESTERONE CAPROATE?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.